These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24026680)

  • 1. CHD7 and retinoic acid signaling cooperate to regulate neural stem cell and inner ear development in mouse models of CHARGE syndrome.
    Micucci JA; Layman WS; Hurd EA; Sperry ED; Frank SF; Durham MA; Swiderski DL; Skidmore JM; Scacheri PC; Raphael Y; Martin DM
    Hum Mol Genet; 2014 Jan; 23(2):434-48. PubMed ID: 24026680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHD7 represses the retinoic acid synthesis enzyme ALDH1A3 during inner ear development.
    Yao H; Hill SF; Skidmore JM; Sperry ED; Swiderski DL; Sanchez GJ; Bartels CF; Raphael Y; Scacheri PC; Iwase S; Martin DM
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mature middle and inner ears express Chd7 and exhibit distinctive pathologies in a mouse model of CHARGE syndrome.
    Hurd EA; Adams ME; Layman WS; Swiderski DL; Beyer LA; Halsey KE; Benson JM; Gong TW; Dolan DF; Raphael Y; Martin DM
    Hear Res; 2011 Dec; 282(1-2):184-95. PubMed ID: 21875659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inner ear manifestations in CHARGE: Abnormalities, treatments, animal models, and progress toward treatments in auditory and vestibular structures.
    Choo DI; Tawfik KO; Martin DM; Raphael Y
    Am J Med Genet C Semin Med Genet; 2017 Dec; 175(4):439-449. PubMed ID: 29082607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome.
    Layman WS; McEwen DP; Beyer LA; Lalani SR; Fernbach SD; Oh E; Swaroop A; Hegg CC; Raphael Y; Martens JR; Martin DM
    Hum Mol Genet; 2009 Jun; 18(11):1909-23. PubMed ID: 19279158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproductive dysfunction and decreased GnRH neurogenesis in a mouse model of CHARGE syndrome.
    Layman WS; Hurd EA; Martin DM
    Hum Mol Genet; 2011 Aug; 20(16):3138-50. PubMed ID: 21596839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the chromatin remodeler CHD7 impacts glial cells and myelination in the mouse cochlear spiral ganglion.
    Ritter KE; Lynch SM; Gorris AM; Beyer LA; Kabara L; Dolan DF; Raphael Y; Martin DM
    Hear Res; 2022 Dec; 426():108633. PubMed ID: 36288662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of fbxl10/kdm2bb rescues chd7 morphant phenotype in a zebrafish model of CHARGE syndrome.
    Balow SA; Pierce LX; Zentner GE; Conrad PA; Davis S; Sabaawy HE; McDermott BM; Scacheri PC
    Dev Biol; 2013 Oct; 382(1):57-69. PubMed ID: 23920116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate p53 activation during development induces features of CHARGE syndrome.
    Van Nostrand JL; Brady CA; Jung H; Fuentes DR; Kozak MM; Johnson TM; Lin CY; Lin CJ; Swiderski DL; Vogel H; Bernstein JA; Attié-Bitach T; Chang CP; Wysocka J; Martin DM; Attardi LD
    Nature; 2014 Oct; 514(7521):228-32. PubMed ID: 25119037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHD7 regulates otic lineage specification and hair cell differentiation in human inner ear organoids.
    Nie J; Ueda Y; Solivais AJ; Hashino E
    Nat Commun; 2022 Nov; 13(1):7053. PubMed ID: 36396635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ATP-dependent chromatin remodeling enzyme CHD7 regulates pro-neural gene expression and neurogenesis in the inner ear.
    Hurd EA; Poucher HK; Cheng K; Raphael Y; Martin DM
    Development; 2010 Sep; 137(18):3139-50. PubMed ID: 20736290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes.
    Engelen E; Akinci U; Bryne JC; Hou J; Gontan C; Moen M; Szumska D; Kockx C; van Ijcken W; Dekkers DH; Demmers J; Rijkers EJ; Bhattacharya S; Philipsen S; Pevny LH; Grosveld FG; Rottier RJ; Lenhard B; Poot RA
    Nat Genet; 2011 Jun; 43(6):607-11. PubMed ID: 21532573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defects in vestibular sensory epithelia and innervation in mice with loss of Chd7 function: implications for human CHARGE syndrome.
    Adams ME; Hurd EA; Beyer LA; Swiderski DL; Raphael Y; Martin DM
    J Comp Neurol; 2007 Oct; 504(5):519-32. PubMed ID: 17701983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHD7 regulates cardiovascular development through ATP-dependent and -independent activities.
    Yan S; Thienthanasit R; Chen D; Engelen E; Brühl J; Crossman DK; Kesterson R; Wang Q; Bouazoune K; Jiao K
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28847-28858. PubMed ID: 33127760
    [No Abstract]   [Full Text] [Related]  

  • 15. CHARGE syndrome protein CHD7 regulates epigenomic activation of enhancers in granule cell precursors and gyrification of the cerebellum.
    Reddy NC; Majidi SP; Kong L; Nemera M; Ferguson CJ; Moore M; Goncalves TM; Liu HK; Fitzpatrick JAJ; Zhao G; Yamada T; Bonni A; Gabel HW
    Nat Commun; 2021 Sep; 12(1):5702. PubMed ID: 34588434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chromatin remodeling protein CHD7, mutated in CHARGE syndrome, is necessary for proper craniofacial and tracheal development.
    Sperry ED; Hurd EA; Durham MA; Reamer EN; Stein AB; Martin DM
    Dev Dyn; 2014 Sep; 243(9):1055-66. PubMed ID: 24975120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse Models for the Dissection of CHD7 Functions in Eye Development and the Molecular Basis for Ocular Defects in CHARGE Syndrome.
    Gage PJ; Hurd EA; Martin DM
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7923-30. PubMed ID: 26670829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8.
    Marie C; Clavairoly A; Frah M; Hmidan H; Yan J; Zhao C; Van Steenwinckel J; Daveau R; Zalc B; Hassan B; Thomas JL; Gressens P; Ravassard P; Moszer I; Martin DM; Lu QR; Parras C
    Proc Natl Acad Sci U S A; 2018 Aug; 115(35):E8246-E8255. PubMed ID: 30108144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple mutations in mouse Chd7 provide models for CHARGE syndrome.
    Bosman EA; Penn AC; Ambrose JC; Kettleborough R; Stemple DL; Steel KP
    Hum Mol Genet; 2005 Nov; 14(22):3463-76. PubMed ID: 16207732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sema3a plays a role in the pathogenesis of CHARGE syndrome.
    Ufartes R; Schwenty-Lara J; Freese L; Neuhofer C; Möller J; Wehner P; van Ravenswaaij-Arts CMA; Wong MTY; Schanze I; Tzschach A; Bartsch O; Borchers A; Pauli S
    Hum Mol Genet; 2018 Apr; 27(8):1343-1352. PubMed ID: 29432577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.